SCHEMBL17346136

SCHEMBL17346136

c1ccc(CSCCNCCN(C2CCCC2)C2CCCC2)cc1

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.40
HPGD P15428 4/20 0.40
LMNA P02545 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
MAPT P10636 2/20 0.37
KMT2A Q03164 6/20 0.36
MEN1 O00255 5/20 0.36
CYP2C19 P33261 3/20 0.36
CYP1A2 P05177 2/20 0.36
CYP3A4 P08684 2/20 0.36
CYP2D6 P10635 2/20 0.36
CYP2C9 P11712 2/20 0.36
NPC1 O15118 1/20 0.35
HTT P42858 1/20 0.35
KCNH2 Q12809 1/20 0.35
OPRM1 P35372 1/20 0.34
OPRD1 P41143 1/20 0.34
OPRK1 P41145 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17346133 0.99 HPGD (0.40) ALDH1A1HPGDLMNASMN1; SMN2MAPT
SCHEMBL17345896 0.86 HPGD (0.39) ALDH1A1HPGDLMNASMN1; SMN2MAPT
SCHEMBL17346340 0.86 SIGMAR1 (0.40) ALDH1A1HPGDLMNASMN1; SMN2CYP2C19
SCHEMBL17345886 0.85 HPGD (0.40) ALDH1A1HPGDLMNASMN1; SMN2MAPT
SCHEMBL17346132 0.85 KMT2A (0.40) ALDH1A1HPGDLMNASMN1; SMN2MAPT
SCHEMBL17346228 0.85 KCNH2 (0.38) ALDH1A1HPGDLMNASMN1; SMN2MAPT
SCHEMBL17346321 0.85 SIGMAR1 (0.42) ALDH1A1HPGDLMNASMN1; SMN2
SCHEMBL17346367 0.84 GRIN2B (0.39) ALDH1A1HPGDLMNASMN1; SMN2MAPT
SCHEMBL17345971 0.84 KCNH2 (0.38) ALDH1A1HPGDLMNASMN1; SMN2MAPT
SCHEMBL17346142 0.84 KMT2A (0.40) ALDH1A1HPGDLMNASMN1; SMN2KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10550139-B2 Polydentate ligands and their complexes for molecular catalysis TRIAD NATIONAL SECURITY, LLC (US) 2020-02-04 US disclosed
US-20170088571-A1 POLYDENTATE LIGANDS AND THEIR COMPLEXES FOR MOLECULAR CATALYSIS TRIAD NATIONAL SECURITY, LLC 2017-03-30 US disclosed
US-20170088571-A1 POLYDENTATE LIGANDS AND THEIR COMPLEXES FOR MOLECULAR CATALYSIS TRIAD NATIONAL SECURITY, LLC 2017-03-30 US disclosed
WO-2015191505-A1 POLYDENTATE LIGANDS AND THEIR COMPLEXES FOR MOLECULAR CATALYSIS LOS ALAMOS NATIONAL SECURITY, LLC (US) 2015-12-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170088571-A1 POLYDENTATE LIGANDS AND THEIR COMPLEXES FOR MOLECULAR CATALYSIS NANS, NCL, NCLN ALDH1A1 862/4885HPGD 973/4885LMNA 3058/4885
US-10550139-B2 Polydentate ligands and their complexes for molecular catalysis NANS, NCL, NCLN ALDH1A1 862/4885HPGD 973/4885LMNA 3058/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.